This is the 32nd in a series of articles analyzing major companies by market capitalization traded on the tech-heavy Kosdaq market. — Ed Daehan New Pharm, a Seoul-based pharmaceutical and animal health product provider, will start selling an anti-cancer supplement next year, entering the market for the first time.